SCHEMBL2861782

SCHEMBL2861782

CC(C)(C)OC(=O)NC(CO)CO

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA7 P43166 1/20 0.52
CTSK P43235 9/20 0.46
CYP2D6 P10635 1/20 0.46
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
CTSS P25774 5/20 0.44
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
APLNR P35414 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL867580 0.92 CA1 (0.46) CA1CA2CA7CTSKCYP2D6
SCHEMBL1809285 0.90 CTSK (0.47) CA1CA2CA7CTSKCYP2D6
SCHEMBL1809284 0.90 CTSK (0.47) CA1CA2CA7CTSKCYP2D6
SCHEMBL102361 0.90 CTSK (0.47) CA1CA2CA7CTSKCYP2D6
SCHEMBL24741997 0.88 CA1 (0.46) CA1CA2CA7CTSKCYP2D6
SCHEMBL7642781 0.88 CA1 (0.46) CA1CA2CA7CTSKCYP2D6
SCHEMBL1764757 0.88 CA1 (0.46) CA1CA2CA7CTSKCYP2D6
SCHEMBL20315237 0.88 CA1 (0.46) CA1CA2CA7CTSKCYP2D6
SCHEMBL17045195 0.88 CA1 (0.46) CA1CA2CA7CTSKCYP2D6
SCHEMBL12666358 0.88 CA1 (0.46) CA1CA2CA7CTSKCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120310033-B PU-FC runway material with high mechanical strength and preparation method thereof 广东盛天体育股份有限公司 2026-05-19 CN claimed
EP-3911795-B1 METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF ISP INVESTMENTS LLC (US) 2025-10-01 EP claimed
CN-119529498-A Degradable environment-friendly tableware and preparation method thereof 宁波昌亚新材料科技股份有限公司 2025-02-28 CN claimed
CN-119463108-A Preparation method of polyurethane polymer dispersing agent for color paste 中山凯普助剂有限公司 2025-02-18 CN claimed
CN-119331232-A Preparation method of degradable bactericide for oil field 东营江源化工有限公司 2025-01-21 CN claimed
CN-118440665-B High-low temperature resistant and super-strong adhesive organic silicon sealant and preparation method thereof 东莞市新懿电子材料技术有限公司 2024-11-12 CN claimed
CN-118440665-A High-low temperature resistant and super-strong adhesive organic silicon sealant and preparation method thereof 东莞市新懿电子材料技术有限公司 2024-08-06 CN claimed
CN-118356410-A Hypoxia response drug delivery nanoparticle adapting to KRAS mutant pancreatic cancer and preparation method thereof 复旦大学 2024-07-19 CN claimed
CN-118147651-A Cleaning rust remover containing surfactant and corrosion inhibitor and preparation method thereof 广东百川化工有限公司 2024-06-07 CN claimed
CN-117486832-A Cationic lipid molecules for RNA delivery capable of achieving early lysosomal escape 清华大学 2024-02-02 CN claimed
CN-112402690-B Woven reinforced degradable polyurethane elastomer artificial blood vessel and preparation method thereof 上海市第六人民医院 2023-03-28 CN claimed
US-11608407-B2 Carbon nanotube-functionalized reverse thermal gel and methods of forming and using same THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2023-03-21 US claimed
US-20220120031-A1 METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF ISP INVESTMENTS LLC (US) 2022-04-21 US claimed
WO-2021027237-A1 METHOD FOR PREPARING SUPERCRITICAL CARBON DIOXIDE THICKENER FOR EXPLOITATION OF TIGHT OIL AND GAS RESERVOIRS 西南石油大学 2021-02-18 WO claimed
CN-107759779-B Antibacterial polyester material and preparation method thereof 东华大学 2020-04-07 CN claimed
CN-120310033-B PU-FC runway material with high mechanical strength and preparation method thereof 广东盛天体育股份有限公司 2026-05-19 CN disclosed
US-12605451-B2 Targeted plasma protein degradation NOVARTIS AG (CH) 2026-04-21 US disclosed
CN-1126988-A Difluoro statone analogs MERRELL DOW PHARMA (US) 1996-07-17 CN disclosed
EP-0707564-A1 DIFLUORO STATONE ANALOGS MERRELL PHARMACEUTICALS INC. (US) 1996-04-24 EP disclosed
WO-1995001958-A1 DIFLUORO STATONE ANALOGS MERRELL PHARMACEUTICALS INC. (US) 1995-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605451-B2 Targeted plasma protein degradation M6PR, ASGR1, IGF2R CA1 3916/4885CA2 4235/4885CA7 3959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.